Allarity Therapeutics, Inc. has announced a research collaboration with the Indiana Biosciences Research Institute (IBRI) to enhance their understanding of stenoparib, a dual PARP and WNT pathway ...
Implement real-time collaboration tools that enable team members to communicate effectively and share updates promptly. This approach minimizes the risk of miscommunication and ensures that everyone ...
LONDON, Dec. 21, 2023 /PRNewswire/ -- Virax Biolabs Group Limited (VRAX) ("Virax" or the "Company"), an innovative biotechnology company focused on the detection of immune responses and diagnosis of ...
As Baltimore’s regional leaders continue efforts to build better communities, we must extend our lens and seek out best practices wherever they might be. This month, more than 70 leaders in government ...
A group of more than 160 researchers and practitioners -- including a University of Wyoming visiting assistant professor -- has released a suite of materials dedicated to advancing understanding of ...
MOUNT PLEASANT, SC / ACCESS Newswire / April 2, 2026 / Deep Sea Rare Minerals, Inc. ("DSRM") today announced that it has entered into a Memorandum of Understanding (the "MoU") with The Metals Company ...
TARPON SPRINGS, Fla., June 4, 2025 -- Allarity Therapeutics, Inc. (ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing stenoparib—a differentiated, dual PARP and WNT pathway ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results